Fisher & Paykel Healthcare Co Ltd 2020 AR2
The report highlights Fisher & Paykel Healthcare's financial and sustainability performance for the fiscal year ended March 31, 2020. During the year, the company's products touched the lives of approximately 16 million patients, including many battling COVID-19. Financially, operating revenue increased by 18% to $1.26 billion, and net profit after tax rose by 37% to $287.3 million. On the sustainability front, the company committed to the Science Based Targets initiative (SBTi) and reduced its Scope 1 and 2 emissions by 3% through the purchase of renewable energy certificates in New Zealand.
Company: Fisher & Paykel Healthcare Co Ltd
Sector: Manufacturing
Country: New Zealand
Year: 2020
Type: AR2
Pages: 116
Back to company
Fisher & Paykel Healthcare Co Ltd
Annual Report
The report highlights Fisher & Paykel Healthcare's financial and sustainability performance for the fiscal year ended March 31, 2020. During the year, the company's products touched the lives of approximately 16 million patients, including many battling COVID-19. Financially, operating revenue increased by 18% to $1.26 billion, and net profit after tax rose by 37% to $287.3 million. On the sustainability front, the company committed to the Science Based Targets initiative (SBTi) and reduced its Scope 1 and 2 emissions by 3% through the purchase of renewable energy certificates in New Zealand.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 1, 2019 - Mar 31, 2020
Fiscal Year
2020
Published
Jun 29, 2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees